Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is neededMark S. Butler, Peter Beyer, Valeria Gigante et al.|Archive ouverte UNIGE (University of Geneva)|2022Cited by 221
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TBConor Tweed, Stephen H. Gillespie, Matt Betteridge et al.|The International Journal of Tuberculosis and Lung Disease|2021Cited by 63
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gapsValeria Gigante, Alexandra Meagan Cameron, Richard A. Alm et al.|Antimicrobial Agents and Chemotherapy|2024Cited by 25